Cardiovascular Effects of GLP-1 Receptor Agonists—From Basic Mechanisms to Clinical Data | American Diabetes Association

Cardiovascular Effects of GLP-1 Receptor Agonists—From Basic Mechanisms to Clinical Data

Speaker: Jens J Holst
Session: Cardiovascular and Renal Protection in Diabetes—Emphasis on SGLT2 Inhibitors and GLP-1 Receptor Agonists
Congress: 79th Scientific Sessions